Theratechnologies Common Stock Shares Outstanding vs Property Plant And Equipment Net Analysis

THTX Stock  USD 1.20  0.01  0.83%   
Theratechnologies financial indicator trend analysis is much more than just breaking down Theratechnologies prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Theratechnologies is a good investment. Please check the relationship between Theratechnologies Common Stock Shares Outstanding and its Property Plant And Equipment Net accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Theratechnologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Theratechnologies Stock please use our How to Invest in Theratechnologies guide.

Common Stock Shares Outstanding vs Property Plant And Equipment Net

Common Stock Shares Outstanding vs Property Plant And Equipment Net Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Theratechnologies Common Stock Shares Outstanding account and Property Plant And Equipment Net. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Theratechnologies' Common Stock Shares Outstanding and Property Plant And Equipment Net is 0.5. Overlapping area represents the amount of variation of Common Stock Shares Outstanding that can explain the historical movement of Property Plant And Equipment Net in the same time period over historical financial statements of Theratechnologies, assuming nothing else is changed. The correlation between historical values of Theratechnologies' Common Stock Shares Outstanding and Property Plant And Equipment Net is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock Shares Outstanding of Theratechnologies are associated (or correlated) with its Property Plant And Equipment Net. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Property Plant And Equipment Net has no effect on the direction of Common Stock Shares Outstanding i.e., Theratechnologies' Common Stock Shares Outstanding and Property Plant And Equipment Net go up and down completely randomly.

Correlation Coefficient

0.5
Relationship DirectionPositive 
Relationship StrengthWeak

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Property Plant And Equipment Net

The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.
Most indicators from Theratechnologies' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Theratechnologies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Theratechnologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Theratechnologies Stock please use our How to Invest in Theratechnologies guide.At this time, Theratechnologies' Tax Provision is fairly stable compared to the past year. Sales General And Administrative To Revenue is likely to rise to 0.34 in 2024, whereas Selling General Administrative is likely to drop slightly above 9.3 M in 2024.
 2021 2022 2023 2024 (projected)
Total Revenue80.1M81.8M94.0M98.7M
Depreciation And Amortization12.0M3.3M3.8M3.1M

Theratechnologies fundamental ratios Correlations

0.90.630.060.420.78-0.570.940.680.79-0.180.430.820.790.680.750.670.750.230.840.940.280.840.510.510.3
0.90.75-0.280.520.83-0.710.80.770.590.130.680.820.810.780.750.550.730.360.910.90.460.660.630.280.44
0.630.75-0.60.580.86-0.710.60.610.310.040.810.660.770.810.350.390.760.560.840.750.810.310.810.290.52
0.06-0.28-0.6-0.39-0.460.570.11-0.330.35-0.38-0.81-0.22-0.41-0.58-0.120.19-0.25-0.61-0.44-0.18-0.460.32-0.730.25-0.44
0.420.520.58-0.390.7-0.220.570.290.050.020.490.330.530.50.330.460.670.70.590.50.340.150.520.470.96
0.780.830.86-0.460.7-0.740.780.590.52-0.080.740.690.870.820.640.640.850.510.920.860.480.530.810.370.56
-0.57-0.71-0.710.57-0.22-0.74-0.4-0.54-0.35-0.03-0.75-0.58-0.65-0.81-0.54-0.38-0.62-0.23-0.74-0.66-0.41-0.26-0.810.07-0.13
0.940.80.60.110.570.78-0.40.560.76-0.350.310.690.740.550.660.730.740.310.770.860.260.820.430.550.42
0.680.770.61-0.330.290.59-0.540.560.450.270.760.950.840.780.80.060.460.550.850.830.230.440.670.260.31
0.790.590.310.350.050.52-0.350.760.45-0.270.130.580.560.30.640.60.4-0.190.560.680.070.870.190.36-0.14
-0.180.130.04-0.380.02-0.08-0.03-0.350.27-0.270.410.140.040.160.12-0.38-0.170.130.1-0.020.15-0.220.03-0.080.15
0.430.680.81-0.810.490.74-0.750.310.760.130.410.710.810.890.560.030.530.680.830.670.490.080.910.120.51
0.820.820.66-0.220.330.69-0.580.690.950.580.140.710.90.840.820.220.60.510.90.930.240.580.70.470.32
0.790.810.77-0.410.530.87-0.650.740.840.560.040.810.90.890.790.290.640.620.950.910.30.570.830.460.47
0.680.780.81-0.580.50.82-0.810.550.780.30.160.890.840.890.660.230.710.650.90.840.40.320.910.370.5
0.750.750.35-0.120.330.64-0.540.660.80.640.120.560.820.790.660.350.50.340.80.82-0.160.630.560.310.26
0.670.550.390.190.460.64-0.380.730.060.6-0.380.030.220.290.230.350.77-0.130.450.550.260.60.20.310.25
0.750.730.76-0.250.670.85-0.620.740.460.4-0.170.530.60.640.710.50.770.410.770.810.460.420.680.50.57
0.230.360.56-0.610.70.51-0.230.310.55-0.190.130.680.510.620.650.34-0.130.410.570.450.23-0.070.680.380.79
0.840.910.84-0.440.590.92-0.740.770.850.560.10.830.90.950.90.80.450.770.570.960.430.560.840.390.51
0.940.90.75-0.180.50.86-0.660.860.830.68-0.020.670.930.910.840.820.550.810.450.960.320.690.720.530.41
0.280.460.81-0.460.340.48-0.410.260.230.070.150.490.240.30.4-0.160.260.460.230.430.320.080.380.050.31
0.840.660.310.320.150.53-0.260.820.440.87-0.220.080.580.570.320.630.60.42-0.070.560.690.080.120.42-0.01
0.510.630.81-0.730.520.81-0.810.430.670.190.030.910.70.830.910.560.20.680.680.840.720.380.120.220.49
0.510.280.290.250.470.370.070.550.260.36-0.080.120.470.460.370.310.310.50.380.390.530.050.420.220.48
0.30.440.52-0.440.960.56-0.130.420.31-0.140.150.510.320.470.50.260.250.570.790.510.410.31-0.010.490.48
Click cells to compare fundamentals

Theratechnologies Account Relationship Matchups

Theratechnologies fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets100.1M119.2M93.3M77.8M89.4M65.2M
Short Long Term Debt Total55.4M56.7M66.7M59.0M67.8M37.4M
Total Current Liabilities41.9M45.1M114.3M47.3M54.4M57.1M
Total Stockholder Equity3.2M17.8M(22.6M)(20.9M)(18.8M)(17.8M)
Property Plant And Equipment Net3.5M2.9M3.1M2.0M1.8M1.3M
Net Debt42.6M36.3M42.9M24.9M28.6M30.0M
Retained Earnings(300.1M)(335.2M)(382.6M)(408.7M)(367.8M)(349.4M)
Accounts Payable17.5M15.5M12.9M7.0M8.0M6.4M
Cash12.7M20.4M23.9M34.1M39.2M41.2M
Non Current Assets Total35.3M27.3M19.9M14.5M16.6M29.9M
Non Currrent Assets Other(35.3M)(26.7M)(18.1M)467K420.3K399.3K
Cash And Short Term Investments20.8M40.4M33.1M40.9M47.0M49.3M
Net Receivables13.2M10.9M12.3M12.8M14.7M15.5M
Common Stock Shares Outstanding19.2M23.1M23.8M26.3M23.7M23.5M
Liabilities And Stockholders Equity100.1M119.2M93.3M77.8M89.4M62.7M
Non Current Liabilities Total55.0M56.4M1.6M51.3M59.0M62.0M
Inventory25.1M29.1M19.7M6.1M7.0M7.8M
Other Current Assets5.7M13.2M10.0M4.0M4.7M4.9M
Other Stockholder Equity12.1M12.8M20.9M23.2M20.9M19.8M
Total Liab96.9M101.5M115.8M98.6M113.4M119.1M
Total Current Assets64.8M91.9M73.4M63.3M72.8M76.4M
Short Term Debt1.1M463K65.3M7.7M8.9M9.2M
Intangible Assets31.9M23.8M15.0M12.5M14.4M13.2M
Other Current Liab23.2M29.0M35.7M32.6M37.5M39.4M
Short Term Investments8.0M20.0M9.2M6.8M6.1M9.6M
Accumulated Other Comprehensive Income(481K)(44K)385K684.0K786.6K430.9K
Property Plant And Equipment Gross3.5M3.6M3.9M3.2M2.9M1.5M
Current Deferred Revenue70K50K54K38K34.2K32.5K
Common Stock287.3M335.8M338.8M363.9M418.5M306.7M
Net Tangible Assets(14.9M)(28.6M)(6.1M)(37.6M)(33.8M)(32.1M)
Long Term Debt50.7M52.4M54.2M50.7M58.3M38.2M
Property Plant Equipment1.1M3.5M2.9M3.1M3.6M3.7M
Net Invested Capital55.6M72.0M42.2M37.1M33.4M45.8M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Theratechnologies Stock Analysis

When running Theratechnologies' price analysis, check to measure Theratechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theratechnologies is operating at the current time. Most of Theratechnologies' value examination focuses on studying past and present price action to predict the probability of Theratechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theratechnologies' price. Additionally, you may evaluate how the addition of Theratechnologies to your portfolios can decrease your overall portfolio volatility.